In this study, a series of bioinformatics analyses based on several large public databases were conducted, and LRRC8A was identified as a possible potent therapeutic target and prognostic biomarker for PAAD based on cell experiments. The gene discussed is LRRC8A; the disease is pancreatic adenocarcinoma.